All In Biotech

Drug Trial Radar · NCT01310777

Brinzolamide/Brimonidine Twice a Day (BID) Fixed Combination (FC) vs Brinzolamide BID and Brimonidine BID in Patients With Open Angle Glaucoma or Ocular Hypertension

Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL/Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension Compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL Eye Drops, Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension

Last checked: Nov 19, 2026Latest source record: Mar 6, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 771 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

771

Actual

Start

May 2011

Primary completion

Jan 2013

Study completion Jan 2013

Sponsor

Lead sponsor
Alcon ResearchIndustry
Sponsor type
Industry
First posted
Mar 9, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study was to evaluate the safety and efficacy of Brinzolamide/Brimonidine in lowering intraocular pressure (IOP) relative to each of its individual active components in patients with open-angle glaucoma or ocular hypertension.

Conditions

  • Open-Angle Glaucoma
  • Ocular Hypertension

Interventions

  • Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspensionDrug

  • Brinzolamide 1% ophthalmic suspensionDrug

  • Brimonidine tartrate 0.2% ophthalmic solutionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Diurnal IOP Change From Baseline at Month 3Time frame: Baseline (Day 1), Month 3

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.